share_log

藥明合聯:董事會會議通告

WUXI XDC: NOTICE OF BOARD MEETING

HKEX ·  Jul 29 17:04

Summary by Moomoo AI

藥明合聯生物技術有限公司宣佈,將於2024年8月20日舉行董事會會議,主要目的是審議及批准該集團截至2024年6月30日止六個月的中期業績及其發佈。該公司由執行董事兼首席執行官李錦才博士領導,董事會成員還包括其他執行董事、非執行董事以及獨立非執行董事。會議將在香港時間2024年7月29日召開。
藥明合聯生物技術有限公司宣佈,將於2024年8月20日舉行董事會會議,主要目的是審議及批准該集團截至2024年6月30日止六個月的中期業績及其發佈。該公司由執行董事兼首席執行官李錦才博士領導,董事會成員還包括其他執行董事、非執行董事以及獨立非執行董事。會議將在香港時間2024年7月29日召開。
WuXi Biologics Holdings Limited announced that it will hold a board of directors meeting on August 20, 2024, the main purpose of which is to review and approve the group's mid-year performance up to June 30, 2024 and its publication. The company is led by Dr. Li Jianguo, executive director and CEO, with other executive directors, non-executive directors, and independent non-executive directors on the board. The meeting will be held on July 29, 2024, Hong Kong time.
WuXi Biologics Holdings Limited announced that it will hold a board of directors meeting on August 20, 2024, the main purpose of which is to review and approve the group's mid-year performance up to June 30, 2024 and its publication. The company is led by Dr. Li Jianguo, executive director and CEO, with other executive directors, non-executive directors, and independent non-executive directors on the board. The meeting will be held on July 29, 2024, Hong Kong time.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more